GLG Partners’s Chemours CC Stock Holding History

GLG Partners’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,638	Closed	-$589K	–	483
2017 Q3	$589K	Buy	+11,638	New	+$549K	0.03%	262
2017 Q2	–	Sell	-7,300	Closed	-$281K	–	339
2017 Q1	$281K	Buy	+7,300	New	+$220K	0.01%	358

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GLG Partners's CC Position: Q4 2017 in Review

GLG Partners sold out of Chemours (CC) in Q4 2017, closing a stake of 11,638 shares — an estimated $589K sold.

GLG Partners first reported a position in CC in Q1 2017 and held it in 2 quarters. The position peaked at $589K in Q3 2017. 538 funds tracked by Wall St. Rank hold CC as of Q4 2017.

GLG Partners reported no remaining Chemours position as of Q4 2017 after selling out during the quarter.
GLG Partners sold 11,638 Chemours shares in Q4 2017, an estimated $589K.
GLG Partners first reported a position in Chemours in Q1 2017 and held it in 2 quarters.
GLG Partners's Chemours position peaked at $589K in Q3 2017.
538 funds tracked by Wall St. Rank held Chemours as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.